Pharma 4.0 Market Size, Share, By Type (Software, and Services), Technology (AI &ML, Big Data Analytics, IoT, Blockchain Technology, and Others), Application (Drug Discovery & Development, Manufacturing, Supply Chain Management, and Others), End Use (Pharma & Biotech companies, Pharma & Biotech Companies Providers, CRO & CDMO, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI580325 | Publish Date: February 2025 | No. of Pages: 169

Pharma 4 0 Market Companies

  • Siemens Pharma & Biotech Companies Private Limited
  • ABB
  • HONEYWELL INTERNATIONAL INC.
  • Pfizer Inc.
  • Cinntra
  • Dassault Systèmes
  • Nexocode
  • QbDVision
  • Electrosan Technologies Pvt Ltd
  • PharmOut Pty Ltd

Recent News:

  • Modicus Prime, resident at Johnson & Johnson Innovation, JLABS @ TMC, has received USD 3.5 million in funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms in July 2024. The funding follows the implementation of Modicus Prime’s mpVision, a Pharma 4.0 quality control technology, across multiple global pharmaceutical companies, CMOs, and CDMOs manufacturing biologics, cell and gene therapies, and vaccines.
  • From 2020 to 2021, Thermo Fisher Scientific in collaboration with Separation Science, hosted PHARMA 4.0. Transforming Pharmaceutical Manufacturing, with eminent global thought leaders covering current and future trends in analytical, process, quality and regulatory issues and their impact on the laboratory of the future as well as its connection to continuous manufacturing.

Pharma 4.0 Market Companies Forecast 2025-2035